Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLUYT-prevent trial
2015-000829-37Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lactated ringer's solution and sodium chloride in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Post-ERCP pancreatitis. Started Apr 2015; status: completed.
02
Drugs
lactated ringer's solutionsodium chloride
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on 2015-000829-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000829-37.